NCT00107094View on ClinicalTrials.gov

Study of Adriamycin Plus Cyclophosphamide Followed by Abraxane as Adjuvant Therapy for Patients With Breast Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2005

Conditions
Breast Cancer
Interventions
DRUG

Abraxane

Trial Locations (1)

27703

Abraxis BioScience Inc., Durham

Sponsors
All Listed Sponsors
lead

Celgene Corporation

INDUSTRY